BC
AGL icon

Brookfield Corp’s Agilon Health AGL Stock Holding History

Brookfield Corp’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,600
Closed -$5.13M – 602
2021
Q4 		$5.13M Sell
7,600
-21,429
-74% -$13M 0.02% 217
2021
Q3 		$19M Buy
29,029
+13,029
+81% +$11.1M 0.08% 96
2021
Q2 		$16.2M Buy
+16,000
New +$14M 0.08% 98

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Brookfield Corp's AGL Position: Q1 2022 in Review

Brookfield Corp sold out of Agilon Health (AGL) in Q1 2022, closing a stake of 7,600 shares — an estimated $5.13M sold.

Brookfield Corp first reported a position in AGL in Q2 2021 and held it in 3 quarters. The position peaked at $19M in Q3 2021. 121 funds tracked by Wall St. Rank hold AGL as of Q1 2022.

  • Brookfield Corp reported no remaining Agilon Health position as of Q1 2022 after selling out during the quarter.
  • Brookfield Corp sold 7,600 Agilon Health shares in Q1 2022, an estimated $5.13M.
  • Brookfield Corp first reported a position in Agilon Health in Q2 2021 and held it in 3 quarters.
  • Brookfield Corp's Agilon Health position peaked at $19M in Q3 2021.
  • 121 funds tracked by Wall St. Rank held Agilon Health as of Q1 2022.

Based on Brookfield Corp's 13F filing for Q1 2022, filed 16 May 2022.